Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.62+0.01 (+0.62%)
Close on Nov 13, 2026Market cap $60.63MP/E –Yield –
Tenax Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Tenax Therapeutics's profit margin for the twelve months ending Apr 30, 2015 was -28571.6%. For fiscal 2015 it was -28571.6%, against -12296.2% the year before. The highest annual figure on record is 10127.6% in fiscal 2011.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Apr 30, 2015 | -28571.6% | −16275.4 |
| FY2014 | Apr 30, 2014 | -12296.2% | −11505.6 |
| FY2013 | Apr 30, 2013 | -790.6% | +3528.6 |
| FY2012 | Apr 30, 2012 | -4319.2% | −14446.8 |
| FY2011 | Apr 30, 2011 | 10127.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | -10118.7% | – |
See a number that looks wrong?